A humanized monoclonal antibody directed against the human immunosuppressive molecule CD200 (OX-2) with potential immunomodulating and antineoplastic … [Read more...]
A
anti-CD22 immunotoxin
A monoclonal antibody linked to a toxic substance. It is being studied in the treatment of some types of B-cell cancer. Anti-CD22 immunotoxin is made in the … [Read more...]
anti-CD22 immunotoxin CAT-8015
A recombinant immunotoxin consisting of the Fv portion of the anti-CD22 antibody covalently fused to a 38 KDa fragment of Pseudomonas exotoxin-A (PE38) with … [Read more...]
anti-CD3 immunotoxin A-dmDT390-bisFv(UCHT1)
A bivalent recombinant fusion protein immunotoxin derived from the anti-CD3 monoclonal antibody UCHT1 with potential antineoplastic activity. Anti-CD3 … [Read more...]
anti-CD30 monoclonal antibody MDX-1401
A fully human, second-generation, nonfucosylated monoclonal antibody directed against the cell surface receptor CD30 with potential immunomodulating and … [Read more...]
anti-CD30 monoclonal antibody XmAb2513
A humanized monoclonal antibody directed against the cell surface receptor CD30 with potential immunotherapeutic activity. Anti-CD30 monoclonal antibody … [Read more...]
anti-CD33 monoclonal antibody-DM4 conjugate AVE9633
An immunoconjugate consisting of the humanized monoclonal antibody huMy9-6 conjugated to the cytotoxic maytansinoid DM4 with potential antineoplastic activity. … [Read more...]
anti-CD37 single-chain polypeptide TRU-016
A recombinant single-chain polypeptide engineered to exhibit the full binding and activity of an anti-CD37 monoclonal antibody with potential immunostimulatory … [Read more...]
anti-CD38 monoclonal antibody
A fully human monoclonal antibody directed against the cell surface glycoprotein CD-38 with potential antineoplastic activity. The binding of anti-CD38 … [Read more...]
anti-CD45 monoclonal antibody
A monoclonal antibody directed against the receptor-like leukocyte cell surface glycoprotein CD45 with leukocyte-depleting activity. Upon administration, … [Read more...]